Inhibitory effects of hexahydro-β-acids in LPS-stimulated murine macrophage

Journal of Functional Foods

Volumn 3, Issue 3, 2011, Pages 215-222

  Tang, Wenping ^a   Chen, Li Hua ^b   Daun, Henryk ^a   Ho, Chi Tang ^a   Pan, Min Hsiung ^b  

^a RUTGERS UNIVERSITY   (United States)

^b NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

Author keywords

Cyclooxygenase 2 (COX 2); Hexahydro acids (HBA); Inducible NO synthesis (iNOS); Mitogen activated protein (MAPK); NF B; Phosphatidylinositol 3 kinase (PI3K)

Indexed keywords

HUMULUS LUPULUS; MURINAE;

EID: 79957659421     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2011.04.004     Document Type: Article

References (37)

1. Agarwal A., Das K., Lerner N., Sathe S., Cicek M., Casey G., et al. The AKT/I kappa B kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-kappa B and beta-catenin. Oncogene 2005, 24:1021-1031.
2. Baeuerle P.A., Henkel T. Function and activation of NF-kappa B in the immune system. Annual Review of Immunology 1994, 12:141-179.
3. Bozinovski S., Jones J.E., Vlahos R., Hamilton J.A., Anderson G.P. Granulocyte/macrophage-colony-stimulating factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through Akt/Erk activation of NFkappa B and AP-1 in vivo. Journal of Biological Chemistry 2002, 277:42808-42814.
4. Carpenter C.L., Cantley L.C. Phosphoinositide kinases. Current Opinion in Cell Biology 1996, 8:153-158.
5. Carson J.F. The hydrogenation of lupulone and humulone. Journal of the American Chemical Society 1951, 73(4):1850-1851.
6. Chandrasekar B., Marelli-Berg F.M., Tone M., Bysani S., Prabhu S.D., Murray D.R. Beta-adrenergic stimulation induces interleukin-18 expression via beta2-AR, PI3K, Akt, IKK, and NF-kappaB. Biochemical and Biophysical Research Communications 2004, 319:304-311.
7. Chen C.C., Wang J.K. P38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages. Molecular Pharmacology 1999, 55:481-488.
8. Chen W.J., Lin J.K. Mechanisms of cancer chemoprevention by hop bitter acids (beer aroma) through induction of apoptosis mediated by Fas and Caspase cascades. Journal of Agricultural and Food Chemistry 2003, 52(1):55-64.
9. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., et al. Cyclooxygenase in biology and disease. FASEB Journal 1998, 12:1063-1073.
10. Geller D.A., Lowenstein C.J., Shapiro R.A., Nussler A.K., Di S.M., Wang S.C., et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:3491-3495.
11. George S.E., Bungay P.J., Naylor L.H. Functional coupling of endogenous serotonin (5-HT1B) and calcitonin (C1a) receptors in CHO cells to a cyclic AMP-responsive luciferase reporter gene. Journal of Neurochemistry 1997, 69:1278-1285.
12. Griscavage J.M., Wilk S., Ignarro L.J. Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:3308-3312.
13. Hattori Y., Hattori S., Kasai K. Lipopolysaccharide activates Akt in vascular smooth muscle cells resulting in induction of inducible nitric oxide synthase through nuclear factor-kappa B activation. European Journal of Pharmacology 2003, 481:153-158.
14. Ho F.M., Lai C.C., Huang L.J., Kuo T.C., Chao C.M., Lin W.W. The anti-inflammatory carbazole, LCY-2-CHO, inhibits lipopolysaccharide-induced inflammatory mediator expression through inhibition of the p38 mitogen-activated protein kinase signaling pathway in macrophages. British Journal of Pharmacology 2004, 141:1037-1047.
15. Je J.H., Lee J.Y., Jung K.J., Sung B., Go E.K., Yu B.P., et al. NF-kappaB activation mechanism of 4-hydroxyhexenal via NIK/IKK and p38 MAPK pathway. FEBS Letters 2004, 566:183-189.
16. Kim H., Lee H.S., Chang K.T., Ko T.H., Baek K.J., Kwon N.S. Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-kappa B. Journal of Immunology 1995, 154:4741-4748.
17. Levy G.N. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer. FASEB Journal 1997, 11:234-247.
18. Liu C.B., Chen L.H., Cheng A.C., Chen W.J., Tsai M.L., Liu Y., et al. Hexahydro-[beta]-acids induce apoptosis through mitochondrial pathway, GADD153 expression, and caspase activation in human leukemia cells. Food and Chemical Toxicology 2011, 10.1016/j.fct.2011.01.016.
19. Liu Y.M., Gu X.H., Tang J., Liu K.F. Antioxidant activities of hops (Humulus lupulus) and their products. Journal of the American Society of Brewing Chemists 2007, 65(2):116-121.
20. Liu Y., Tang J., Liu K., Chen D. Synthesis technology of hexahydro-beta-acids, a novel antibacterial agent. Shipin Gongye Keji 2008, 29(11):225-229.
21. Mann J.R., Backlund M.G., DuBois R.N. Mechanisms of disease: Inflammatory mediators and cancer prevention. Nature Clinical Practice Oncology 2005, 2:202-210.
22. Nathan C., Xie Q.W. Nitric oxide synthases: Roles, tolls, and controls. Cell 1994, 78:915-918.
23. Nick J.A., Young S.K., Brown K.K., Avdi N.J., Arndt P.G., Suratt B.T., et al. Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation. Journal of Immunology 2000, 164:2151-2159.
24. Nosho K., Yoshida M., Yamamoto H., Taniguchi H., Adachi Y., Mikami M., et al. Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis. Carcinogenesis 2005, 26:892-899.
25. Pan M.H., Chang Y.H., Tsai M.L., Lai C.S., Ho S.Y., Bsdmaev V., et al. Pterostilbene suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages. Journal of Agricultural and Food Chemistry 2008, 56:7502-7509.
26. Pan M.H., Hsieh M.C., Hsu P.C., Ho S.Y., Lai C.S., Wu H., et al. 6-Shogaol suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages. Molecular Nutrition and Food Research 2008, 52:1467-1477.
27. Pan M.H., Lin-Shiau S.Y., Ho C.T., Lin J.H., Lin J.K. Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3′-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages. Biochemical Pharmacology 2000, 59:357-367.
28. Raingeaud J., Gupta S., Rogers J.S., Dickens M., Han J., Ulevitch R.J., et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. Journal of Biological Chemistry 1995, 270:7420-7426.
29. Rockey D.C., Chung J.J., McKee C.M., Noble P.W. Stimulation of inducible nitric oxide synthase in rat liver by hyaluronan fragments. Hepatology 1998, 27:86-92.
30. Sheu M.L., Chao K.F., Sung Y.J., Lin W.W., Lin-Shiau S.Y., Liu S.H. Activation of phosphoinositide 3-kinase in response to inflammation and nitric oxide leads to the up-regulation of cyclooxygenase-2 expression and subsequent cell proliferation in mesangial cells. Cellular Signalling 2005, 17:975-984.
31. Sizemore N., Leung S., Stark G.R. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Molecular and Cellular Biology 1999, 19:4798-4805.
32. Stephan T.E., Ngo E.O., Nutter L.M. Hexahydrocolupulone and its antitumor cell proliferation activity in vitro. Biochemical Pharmacology 1998, 55(4):505-514.
33. Suh N., Honda T., Finlay H.J., Barchowsky A., Williams C., Benoit N.E., et al. Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Research 1998, 58:717-723.
34. Tagashira M., Watanabe M., Uemitsu N. Antioxidative activity of hop bitter acids and their analogues. Bioscience, Biotechnology, and Biochemistry 1995, 59(4):740-742.
35. Van Cleemput M., Heyerick A., ClaudeSwerts L., Katrien S., Philippé J., DeKeukeleire D., et al. Hop bitter acids efficiently block inflammation independent of GRα, PPARα, or PPARγ. Molecular Nutrition and Food Research 2009, 53(9):1143-1155.
36. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-κ B/Rel in induction of nitric oxide synthase. Journal of Biological Chemistry 1994, 269:4705-4708.
37. Yasukawa K., Takeuchi M., Takido M. Humulon, a bitter in the hop, inhibits tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Oncology 1995, 52(2):156-158.